A randomized, open-label, 2 way crossover study to assess the reciprocal effects of co-administration of rosuvastatin 40 mg and ezetimibe 10 mg on the steady state pharmacokinetics of each drug
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 28 Mar 2006
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Lipid metabolism disorders
- Focus Pharmacokinetics
- 28 Mar 2006 New trial record.